Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or n...

Buy Now From Amazon

Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. In this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. The following topics, amongst others, are covered in this book: * Description of the FDA drug trial process, from pre-clinical to Phase III & beyond * Identification, categorization & organization of small cap biotech companies * Structured & streamlined approach to assess small cap biotech companies * Notes on trading strategy & tactics * Detailed description of option trading structures best suited for small cap biotech This book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech.

Similar Products

The Biotech Investor: How to Profit from the Coming Boom in BiotechnologyNew Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and PatientsHow To Swing Trade: A Beginner’s Guide to Trading Tools, Money Management, Rules, Routines and Strategies of a Swing TraderMiddle-Class Millionaire: From $80K in Debt to $3M in Profits through Catalyst TradingSwing Trading with Options: How to Trade Big Trends for Big ProfitsBuy Then Build: How Acquisition Entrepreneurs Outsmart the Startup GameSwing Trading For Dummies